BRIEF—Ex-Harvard Medical man named CMO of Aprea

Privately-held oncology specialist Aprea Therapeutics has recruited Eyal Attar to the role of senior vice president and chief medical officer.

Dr Attar joins from Agios Pharmaceuticals, where he was senior medical director and IDH hematology medical lead.

Prior to Agios, he served on the clinical staff at the Massachusetts General Hospital Cancer Center, where Dr Attar was a member of the Center for Leukemia and assistant professor of medicine at Harvard Medical School.

Christian Schade, president and chief executive of Aprea, said: “Dr Attar's deep medical and biotech industry experiences will strengthen our clinical development efforts as we continue to advance our first-in-class p53 reactivating agents in late-stage clinical studies.”